These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5068872)

  • 1. [Study on tablets. XX. Further knowledge of powdered and microcrystalline cellulose].
    Heliová M; Chalabala M; Malý J
    Cesk Farm; 1972 Jul; 21(6):261-6. PubMed ID: 5068872
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the effect of some pharmaceutic aids on the physical properties of tablets].
    Sümegi G; Kedvessy G
    Pharmazie; 1970 Sep; 25(9):544-6. PubMed ID: 5486682
    [No Abstract]   [Full Text] [Related]  

  • 3. The compression characteristics of microcrystalline cellulose powders.
    Sixsmith D
    J Pharm Pharmacol; 1982 May; 34(5):345-6. PubMed ID: 6123582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of microcrystalline cellulose on the properties of phenobarbital tablets].
    Szabóné Révész P; Pintyéné Hódi K; Miseta M; Selmeczi B
    Acta Pharm Hung; 1984 Jul; 54(4):181-6. PubMed ID: 6485812
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmaceutical granulation technology].
    Dittgen M; Kala H; Moldenhauer H; Zessin G; Schneider J
    Pharmazie; 1980; 35(4):237-49. PubMed ID: 7403250
    [No Abstract]   [Full Text] [Related]  

  • 6. Solid state stability of acetylsalicylic acid in binary mixtures with microcrystalline and microfine cellulose.
    Ahlneck C; Alderborn G
    Acta Pharm Suec; 1988; 25(1):41-52. PubMed ID: 3414383
    [No Abstract]   [Full Text] [Related]  

  • 7. [Binding activity of hydroxypropyl cellulose (PM 200.000 and 1,000.000) and its influence on the physical characteristics of granulations and tablets].
    Delonca H; Joachim J; Mattha AG
    Farmaco Prat; 1977 Apr; 32(4):157-71. PubMed ID: 862868
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of particle size of acetylsalicylic acid on the dissolution rate of tablets].
    Cid E; Jaminet F
    Farmaco Prat; 1972 May; 27(5):298-304. PubMed ID: 5025713
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of the influence of formulation factors and processing techniques on the dissolution rates of hydrochlorothiazide tablets.
    Seth P
    Pharm Acta Helv; 1972; 47(6):457-65. PubMed ID: 5044950
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmaceutical studies on physical properties of solid form drugs. IV. Behavior of powders in tabletting (author's transl)].
    Kigasawa K; Iimura H; Tanizaki A; Sugahara S; Watabe K; Sugimura H; Shimizu H
    Yakugaku Zasshi; 1979 Jul; 99(7):723-9. PubMed ID: 544790
    [No Abstract]   [Full Text] [Related]  

  • 11. Particle size distribution of the active ingredient for solid dosage forms of low dosage.
    Johnson MC
    Pharm Acta Helv; 1972; 47(8):546-59. PubMed ID: 5076852
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in material properties accompanying the national formulary (NF) identity test for microcrystalline cellulose.
    Brittain HG; Lewen G; Newman AW; Fiorelli K; Bogdanowich S
    Pharm Res; 1993 Jan; 10(1):61-7. PubMed ID: 8430061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastroresistant cellulose acetophthalate coatings. III.-Physical properties of isolated films of various thicknesses].
    Lefort des Ylouses D; Chaumeil JC
    Ann Pharm Fr; 1974; 32(3-4):203-13. PubMed ID: 4433121
    [No Abstract]   [Full Text] [Related]  

  • 14. [Direct compression: contribution to the measurement of pressure].
    Pourcelot-Roubeau Y; Jeannin C; Verain A
    J Pharm Belg; 1972; 27(5):600-8. PubMed ID: 4660647
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sedimentation and sedimentation retarders, especially celluloses, with a pharmacopoeia proposal "cellulose powder"].
    Graf E; Graser M; Walker R
    Arch Pharm Ber Dtsch Pharm Ges; 1971 Mar; 304(3):61-84. PubMed ID: 4946886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the strength of compacts of mixed dry binders consisting of powdered cellulose and directly compressible lactose].
    Muzíková J; Hájková P; Vinklarová S
    Ceska Slov Farm; 2004 Jul; 53(4):183-6. PubMed ID: 15369229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
    Jójárt-Laczkovich O; Szabó-Révész P
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parameters influencing the flow rate of diluent agents used in direct compression].
    Gillard J; Delattre L; Jaminet F; Roland M
    J Pharm Belg; 1972; 27(6):713-42. PubMed ID: 4665016
    [No Abstract]   [Full Text] [Related]  

  • 19. An investigation of the pore structure of tablets of sucrose and lactose by mercury porosimetry.
    Selkirk AB; Ganderton D
    J Pharm Pharmacol; 1970 Dec; ():Suppl:79S+. PubMed ID: 4395587
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979; 34(3):164-7. PubMed ID: 450956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.